MAXHEALTH - Swing Trade Analysis with AI Signals
← Back to ListKey Parameters
⭐ Swing Trade Rating: 3.2
✅ Positive
MaxHealth exhibits strong recent earnings growth with PAT increasing by 14.6% QoQ, alongside a healthy ROCE of 10.5%. The company also recently announced an increased dividend payout of ₹2 per share, offering some returns to investors. Furthermore, the DII holding has increased significantly while FII holding has decreased.
⚠️ Limitation
The stock trades at a very high P/E ratio of 146, significantly above the industry average of 48.5, indicating potential overvaluation. Moreover, the PEG Ratio is exceptionally high at 88.8, suggesting that the current price doesn't fully account for expected earnings growth.
📉 Company Negative News
None found
📈 Company Positive News
MaxHealthcare shareholders approved a ₹2 dividend payout and there was an announcement regarding a shift of Haryana office by scanx.trade.
🏭 Industry
The private hospital sector in India is experiencing significant growth driven by rising healthcare awareness, increasing disposable incomes, and government initiatives promoting medical infrastructure development. Competition within the industry remains intense, with major players like Apollo Hospitals and Fortis Healthcare vying for market share.
🧾 Conclusion
Considering the strong earnings momentum and dividend yield, a potential entry point could be around 1,065 ₹, targeting a profit taking exit at 1,120 ₹ if the stock continues its upward trend. However, given the high valuation, investors should exercise caution and monitor the stock closely for any signs of market correction or slowing growth. Overall, it's a moderately risky swing trading candidate.